Development of ReproKnow, a reproductive knowledge assessment for women with rheumatic diseases

[1] Clowse ME(2008)A national study of the complications of lupus in pregnancy Am J Obstet Gynecol 199 127 e121-127 e126

[2] Jamison M(2013)Pregnancy outcomes among patients with vasculitis Arthritis Care Res 65 1370-1374

[3] Myers E(2007)Pregnancy outcome in idiopathic inflammatory myopathy Rheumatol Int 27 435-439

[4] James AH(2004)A prospective study of pregnant patients with rheumatoid arthritis and ankylosing spondylitis using validated clinical instruments Ann Rheum Dis 63 1212-1217

[5] Clowse ME(2015)Pregnancy outcomes in women with rare autoimmune diseases Arthritis Rheumatol 67 3314-3323

[6] Richeson RL(2016)BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding-part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids Rheumatology (Oxford) 55 1693-1697

[7] Pieper C(2016)BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding-part II: analgesics and other drugs used in rheumatology practice Rheumatology (Oxford) 55 1698-1702

[8] Merkel PA(2005)A trial of contraceptive methods in women with systemic lupus erythematosus N Engl J Med 353 2539-2549

[9] Vancsa A(2005)Combined oral contraceptives in women with systemic lupus erythematosus N Engl J Med 353 2550-2558

[10] Ponyi A(2017)EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome Ann Rheum Dis 76 476-485

[1] Clowse ME(2008)A national study of the complications of lupus in pregnancy Am J Obstet Gynecol 199 127 e121-127 e126

[2] Jamison M(2013)Pregnancy outcomes among patients with vasculitis Arthritis Care Res 65 1370-1374

[3] Myers E(2007)Pregnancy outcome in idiopathic inflammatory myopathy Rheumatol Int 27 435-439

[4] James AH(2004)A prospective study of pregnant patients with rheumatoid arthritis and ankylosing spondylitis using validated clinical instruments Ann Rheum Dis 63 1212-1217

[5] Clowse ME(2015)Pregnancy outcomes in women with rare autoimmune diseases Arthritis Rheumatol 67 3314-3323

[6] Richeson RL(2016)BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding-part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids Rheumatology (Oxford) 55 1693-1697

[7] Pieper C(2016)BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding-part II: analgesics and other drugs used in rheumatology practice Rheumatology (Oxford) 55 1698-1702

[8] Merkel PA(2005)A trial of contraceptive methods in women with systemic lupus erythematosus N Engl J Med 353 2539-2549

[9] Vancsa A(2005)Combined oral contraceptives in women with systemic lupus erythematosus N Engl J Med 353 2550-2558

[10] Ponyi A(2017)EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome Ann Rheum Dis 76 476-485